FDA Determines Regulatory Review Period for Patent Extension of CPI Ventak P2 AICD System

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for the CPI Ventak P2 AICD System, a medical device, in accordance with federal regulations, following a patent extension application submitted to the US Department of Commerce.